Department of Orthopaedic Surgery, Tauranga Hospital, Private Bag 12024, Tauranga, 3143, New Zealand.
Department of Medicine, The University of Otago, Christchurch, New Zealand.
Arch Orthop Trauma Surg. 2023 Jun;143(6):3597-3604. doi: 10.1007/s00402-022-04610-2. Epub 2022 Sep 14.
Multiple joint registries have reported better implant survival for patients aged > 75 years undergoing total hip arthroplasty (THA) with cemented implant combinations when compared to hybrid or uncemented implant combinations. However, there is considerable variation within these broad implant categories, and it has therefore been suggested that specific implant combinations should be compared. We analysed the most common contemporary uncemented (Corail/Pinnacle), hybrid (Exeter V40/Trident) and cemented (Exeter V40/Exeter X3) implant combinations in the New Zealand Joint Registry (NZJR) for patients aged > 75 years.
All THAs performed using the selected implants in the NZJR for patients aged > 75 years between 1999 and 2018 were included. Demographic data, implant type, and outcome data including implant survival, reason for revision, and post-operative Oxford Hip Scores were obtained from the NZJR, and detailed survival analyses were performed. Primary outcome was revision for any reason. Reason for revision, including femoral or acetabular failure, and time to revision were recorded.
5427 THAs were included. There were 1105 implantations in the uncemented implant combination group, 3040 in the hybrid implant combination group and 1282 in the cemented implant combination group. Patient reported outcomes were comparable across all groups. Revision rates were comparable between the cemented implant combination (0.31 revisions/100 component years) and the hybrid implant combination (0.40 revisions/100 component years) but were statistically significantly higher in the uncemented implant combination (0.80/100 component years). Femoral-sided revisions were significantly greater in the uncemented implant combination group.
The cemented implant and hybrid implant combinations provide equivalent survival and functional outcomes in patients aged over 75 years. Caution is advised if considering use of the uncemented implant combination in this age group, predominantly due to a higher risk of femoral-sided revisions. The authors recommend comparison of individual implants rather than broad categories of implants.
多个关节登记处报告称,与混合或非骨水泥植入物组合相比,对于接受骨水泥植入物组合的年龄> 75 岁的全髋关节置换术(THA)患者,使用全髋关节置换术(THA)的患者具有更好的植入物存活率。然而,在这些广泛的植入物类别中存在相当大的差异,因此有人建议应比较特定的植入物组合。我们分析了新西兰关节登记处(NZJR)中最常见的当代非骨水泥(Corail/Pinnacle),混合(Exeter V40/Trident)和骨水泥(Exeter V40/Exeter X3)植入物组合,这些组合适用于年龄> 75 岁的患者。
我们纳入了 1999 年至 2018 年间在新西兰关节登记处中使用选定植入物的所有年龄> 75 岁的患者进行的所有 THA。从新西兰关节登记处获得了人口统计学数据,植入物类型以及包括植入物存活率,翻修原因和术后牛津髋关节评分在内的结果数据,并进行了详细的生存分析。主要结果是任何原因的翻修。记录了翻修的原因,包括股骨或髋臼失败以及翻修时间。
共纳入 5427 例 THA。非骨水泥植入物组合组中有 1105 例植入物,混合植入物组合组中有 3040 例植入物,骨水泥植入物组合组中有 1282 例植入物。所有组的患者报告结果均相似。骨水泥植入物组合(0.31 次/ 100 个组件年)和混合植入物组合(0.40 次/ 100 个组件年)之间的翻修率相似,但在非骨水泥植入物组合中显着更高(0.80/100 个组件年)。非骨水泥植入物组合组的股骨侧翻修明显更多。
对于年龄> 75 岁的患者,骨水泥植入物和混合植入物组合提供了等效的生存和功能结果。如果考虑在该年龄组中使用非骨水泥植入物组合,则应谨慎,主要是因为股骨侧翻修的风险较高。作者建议比较单个植入物而不是广泛的植入物类别。